Hoge Michael
Known title: Senior VP Global OperationsCIK: 0001825890
Associated companies
Transaction History
| ARAY | ▼ Sell | Tax Withholding | 24,675 | $53K | 12/2/2024 | View on chart |
| ARAY | ▼ Sell | Tax Withholding | 8,102 | $15K | 9/30/2024 | View on chart |
| ARAY | ▼ Sell | Open Market | 11,991 | $31K | 3/1/2024 | View on chart |
| ARAY | ▼ Sell | Open Market | 19,212 | $47K | 12/1/2023 | View on chart |
| ARAY | ▲ Buy | Grant | 113,207 | $0 | 11/30/2023 | View on chart |
| ARAY | ▼ Sell | Open Market | 8,353 | $22K | 10/3/2023 | View on chart |
| ARAY | ▼ Sell | Open Market | 11,977 | $35K | 3/1/2023 | View on chart |
| ARAY | ▼ Sell | Open Market | 5,531 | $12K | 12/1/2022 | View on chart |
| ARAY | ▲ Buy | Grant | 118,110 | $0 | 11/30/2022 | View on chart |
| ARAY | ▲ Buy | Grant | 118,110 | $0 | 11/30/2022 | View on chart |
| ARAY | ▼ Sell | Open Market | 8,324 | $17K | 10/3/2022 | View on chart |
| ARAY | ▼ Sell | Open Market | 11,653 | $40K | 3/1/2022 | View on chart |
| ARAY | ▼ Sell | Open Market | 5,672 | $26K | 12/2/2021 | View on chart |
| ARAY | ▲ Buy | Grant | 75,949 | $0 | 9/30/2021 | View on chart |
| ARAY | ▲ Buy | Grant | 75,949 | $0 | 9/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Accuray (ARAY) noted among health‑care stocks moving in recent sessions
Accuray appeared in several recent lists of health‑care stocks showing price movement in pre‑market, after‑market and intraday sessions. The activity comes as the stock trades near its $0.25 support level with an RSI around 58, suggesting modest momentum. Analysts have an average target of $0.35, above the current price.
Accuray (ARAY) noted among health‑care stocks moving in recent sessions. Accuray appeared in several recent lists of health‑care stocks showing price movement in pre‑market, after‑market and intraday sessions. The activity comes as the stock trades near its $0.25 support level with an RSI around 58, suggesting modest momentum. Analysts have an average target of $0.35, above the current price.